454 and Baylor First Report Re-Sequencing Full Human Genome; High Cost Bars Broad Use | GenomeWeb
Next-generation sequencing technologies have reached the market, but how close are they to ushering in the era of personal genomics?
Researchers at 454 Life Sciences and Baylor College of Medicine have now subjected the Genome Sequencer FLX to the ultimate test: re-sequencing an entire human genome.
At the Advances in Genome Biology and Technology in Marco Island, Fla., last month, two scientists, in separate talks, presented initial results from the ongoing study.
Up until recently, no one had re-sequ

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.